You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

NORGESTREL AND ETHINYL ESTRADIOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Norgestrel And Ethinyl Estradiol patents expire, and what generic alternatives are available?

Norgestrel And Ethinyl Estradiol is a drug marketed by Mylan Labs Ltd and is included in two NDAs.

The generic ingredient in NORGESTREL AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORGESTREL AND ETHINYL ESTRADIOL?
  • What are the global sales for NORGESTREL AND ETHINYL ESTRADIOL?
  • What is Average Wholesale Price for NORGESTREL AND ETHINYL ESTRADIOL?
Summary for NORGESTREL AND ETHINYL ESTRADIOL
Drug patent expirations by year for NORGESTREL AND ETHINYL ESTRADIOL
Recent Clinical Trials for NORGESTREL AND ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AmgenPhase 1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1
National Cancer Institute (NCI)Phase 2

See all NORGESTREL AND ETHINYL ESTRADIOL clinical trials

US Patents and Regulatory Information for NORGESTREL AND ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd NORGESTREL AND ETHINYL ESTRADIOL ethinyl estradiol; norgestrel TABLET;ORAL-28 201828-001 Jun 21, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Labs Ltd NORGESTREL AND ETHINYL ESTRADIOL ethinyl estradiol; norgestrel TABLET;ORAL-28 202875-001 May 8, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.